This article outlines the coding guidelines for Hep B Vaccine with a list of CPT Codes (CPT 90740, CPT 90743, CPT 90744, CPT 90746 & CPT 90747). The administration codes for Hep B Vaccine are CPT 90471 & CPT 90472.
List With CPT Codes For Hep B Vaccine
Description of CPT code 90740: Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (3 dose schedule for intramuscular use.
Description of CPT code 90743: Hepatitis B vaccine, adolescent (2 dose schedule) for intramuscular use.
Description of CPT code 90744: Hepatitis B vaccine, pediatric/adolescent (3 dose schedule) for intramuscular use.
Description of CPT code 90746: Hepatitis B vaccine, adult dosage, for intramuscular use.
Description of CPT code 90747: Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (4 dose schedule for intramuscular use.
List With Administration Codes For Hep B Vaccine
Description of CPT code 90471: Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid).
Description of CPT code 90472: Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)
TIP: You can find the complete billing guide for CPT 90472 here.
Coding Guidelines For Hep B Vaccine
Report CPT 90740 for a 3-dose schedule for a dialysis or immunosuppressed patient; CPT 90743 for an adolescent 2-dose schedule; CPT 90744 for a pediatric/adolescent 3-dose schedule; CPT 90746 for an adult dosage; and CPT 90747 for a 4-dose schedule for a dialysis or immunosuppressed patient.
For CPT 90746 please report CPT 90471 / 90472 as its administration code.
CDC – Childhood Immunization Schedule – Hepatitis B Vaccine
Minimum age at birth
Administer monovalent HepB to all newborns prior to hospital discharge.
If mother is hepatitis B surface antigen (HBsAg)-positive, administer HepB and 0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth.
If mother’s HBsAg status is unknown, administer HepB within 12 hours of birth. Determine the HBsAg status as soon as possible and if HBsAg-positive, administer HBIG (no later than age 1 week).
If mother is HBsAg-negative, the birth dose can be delayed, in rare cases, with a provider’s order and a copy of the mother’s negative HBsAg laboratory report in the infant’s medical record.
After the birth dose
The HepB series should be completed with either monovalent HepB or a combination vaccine containing HepB.
The second dose should be administered at age 1–2 months. The final dose should be administered no earlier than age 24 weeks.
Infants born to HBsAg-positive mothers should be tested for HBsAg and antibody to HBsAg after completion of at least 3 doses of a licensed HepB series, at age 9–18 months (generally at the next well-child visit).
It is permissible to administer 4 doses of HepB when combination vaccines are administered after the birth dose.
If monovalent HepB is used for doses after the birth dose, a dose at age 4 months is not needed.